Abstract
Central venous thrombosis is a complex problem, particularly in cases where the thrombus
burden is large. Several interventional techniques and devices have been developed
over the past 15 to 20 years to manage this entity, but the vast majority of them
still need the concomitant use of thrombolytics to achieve an optimal result. AngioVac
(AngioDynamics, Latham, NY) is the first aspiration thrombectomy device capable to
remove a larger burden of undesired intravascular material such as thrombus, tumor,
and foreign bodies without the need of lytics. This review focuses on the AngioVac
device in the management of iliocaval thrombosis and pulmonary embolism.
Keywords
pulmonary embolism - thrombolysis - IVC thrombosis - interventional radiology